Cours Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Actions
IL0010810096
Produits pharmaceutiques
CA 2022 | 292 M 77,65 M 29,24 Md 69,76 M | CA 2023 | 322 M 85,43 M 32,17 Md 76,74 M | Capitalisation | 169 M 44,8 M 16,87 Md 40,25 M |
---|---|---|---|---|---|
Résultat net 2022 | -2 M -531 k -200 M -477 k | Résultat net 2023 | -6 M -1,59 M -600 M -1,43 M | VE / CA 2022 | 1,1 x |
Dette nette 2022 | 145 M 38,62 M 14,54 Md 34,69 M | Dette nette 2023 | 166 M 44,2 M 16,64 Md 39,71 M | VE / CA 2023 | 1,04 x |
PER 2022 |
-85,5
x | PER 2023 |
-24,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 17,36% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,15% | 75,76 Md | |
-2,46% | 23,95 Md | |
+14,23% | 8,7 Md | |
+1,47% | 8,29 Md | |
-32,92% | 6,7 Md | |
+18,62% | 5,38 Md | |
+1,10% | 4,08 Md | |
-9,24% | 3,79 Md | |
-10,20% | 3,3 Md |